x

Search for a clinical trial

* (*) mandatory field

A Phase 3 trial of Setmelanotide (RM-493), a Melanocortin-4 Receptor (MC4R) Agonist, in Bardet-Biedl Syndrome (BBS) and AlstrC6m syndrome (AS) Patients with Moderate to Severe Obesity - ES

  • Type of clinical trial : Drug clinical trial
  • Recruiting project : No
  • Status : Ongoing trial
  • Funding body(ies) :
  • Geographic coverage : Global
  • Sponsor : Rhythm pharmaceuticals, inc.
    • Phase : III
  • Principal investigator of clinical trial

  • INFORMATION NOT PROVIDED
  • Servicio de Endocrinologa, Crecimiento y Metabolismo
  • Hospital Infantil Universitario Nio Jess
  • Avenida Menendez y Pelayo, 65
  • 28009 MADRID
  • SPAIN
  • More information
  • Phone  : 34 91 503 59 15
  • Fax  : -
  • Website
Last update: November 2020

Additional information

The documents contained in this web site are presented for information purposes only. The material is in no way intended to replace professional medical care by a qualified specialist and should not be used as a basis for diagnosis or treatment.